Allosteric cooperation in ß-lactam binding to a non-classical transpeptidase

  1. Nazia Ahmad
  2. Sanmati Dugad
  3. Varsha Chauhan
  4. Shubbir Ahmed
  5. Kunal Sharma
  6. Sangita Kachhap
  7. Rana Zaidi
  8. William R Bishai
  9. Gyanu Lamichhane  Is a corresponding author
  10. Pankaj Kumar  Is a corresponding author
  1. Jamia Hamdard University, India
  2. Johns Hopkins University, United States
  3. Translational Health Science and Technology Institute, India
  4. Polish Academy of Sciences, Poland

Abstract

L,D-transpeptidase function predominates in atypical 3®3 transpeptide networking of peptidoglycan (PG) layer in Mycobacterium tuberculosis. Prior studies of L,D-transpeptidases have identified only the catalytic site that binds to peptide moiety of the PG substrate or ß-lactam antibiotics. This insight was leveraged to develop mechanism of its activity and inhibition by ß-lactams. Here we report identification of an allosteric site at a distance of 21 Å from the catalytic site that binds the sugar moiety of PG substrates (hereafter referred to as the S-pocket). This site also binds a second ß-lactam molecule and influences binding at the catalytic site. We provide evidence that two ß-lactam molecules bind co-operatively to this enzyme, one non-covalently at the S-pocket and one covalently at the catalytic site. This dual ß-lactam binding phenomenon is previously unknown and is an observation that may offer novel approaches for the structure-based design of new drugs against M. tuberculosis./em>.

Data availability

Diffraction data have been deposited in PDB under the accession code 7F71, 7F8P

The following data sets were generated

Article and author information

Author details

  1. Nazia Ahmad

    Department of Biochemistry, Jamia Hamdard University, Delhi, India
    Competing interests
    The authors declare that no competing interests exist.
  2. Sanmati Dugad

    Department of Infectious Diseases, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Varsha Chauhan

    Department of Infectious Diseases, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Shubbir Ahmed

    NCR Biotech Science Cluster, Translational Health Science and Technology Institute, Faridabad, India
    Competing interests
    The authors declare that no competing interests exist.
  5. Kunal Sharma

    Department of Biochemistry, Jamia Hamdard University, Delhi, India
    Competing interests
    The authors declare that no competing interests exist.
  6. Sangita Kachhap

    Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek, Poland
    Competing interests
    The authors declare that no competing interests exist.
  7. Rana Zaidi

    Department of Biochemistry, Jamia Hamdard University, Delhi, India
    Competing interests
    The authors declare that no competing interests exist.
  8. William R Bishai

    Department of Infectious Diseases, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8734-4118
  9. Gyanu Lamichhane

    Department of Infectious Diseases, Johns Hopkins University, Baltimore, United States
    For correspondence
    gyanu@jhu.edu
    Competing interests
    The authors declare that no competing interests exist.
  10. Pankaj Kumar

    Medicine, Johns Hopkins University, Baltimore, United States
    For correspondence
    pkumar10@jhmi.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9163-3273

Funding

Science and Engineering Research Board (CRG/2019/005079)

  • Pankaj Kumar

National Institutes of Health (R33 AI111739)

  • Gyanu Lamichhane

National Institutes of Health (R21 R01 AI155664)

  • Gyanu Lamichhane

Department of Biotechnology, Ministry of Science and Technology, India (BT-RLF/Re-entry/68/2017)

  • Pankaj Kumar

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2022, Ahmad et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,548
    views
  • 321
    downloads
  • 2
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nazia Ahmad
  2. Sanmati Dugad
  3. Varsha Chauhan
  4. Shubbir Ahmed
  5. Kunal Sharma
  6. Sangita Kachhap
  7. Rana Zaidi
  8. William R Bishai
  9. Gyanu Lamichhane
  10. Pankaj Kumar
(2022)
Allosteric cooperation in ß-lactam binding to a non-classical transpeptidase
eLife 11:e73055.
https://doi.org/10.7554/eLife.73055

Share this article

https://doi.org/10.7554/eLife.73055

Further reading

    1. Biochemistry and Chemical Biology
    2. Stem Cells and Regenerative Medicine
    Alejandro J Brenes, Eva Griesser ... Angus I Lamond
    Research Article

    Human induced pluripotent stem cells (hiPSCs) have great potential to be used as alternatives to embryonic stem cells (hESCs) in regenerative medicine and disease modelling. In this study, we characterise the proteomes of multiple hiPSC and hESC lines derived from independent donors and find that while they express a near-identical set of proteins, they show consistent quantitative differences in the abundance of a subset of proteins. hiPSCs have increased total protein content, while maintaining a comparable cell cycle profile to hESCs, with increased abundance of cytoplasmic and mitochondrial proteins required to sustain high growth rates, including nutrient transporters and metabolic proteins. Prominent changes detected in proteins involved in mitochondrial metabolism correlated with enhanced mitochondrial potential, shown using high-resolution respirometry. hiPSCs also produced higher levels of secreted proteins, including growth factors and proteins involved in the inhibition of the immune system. The data indicate that reprogramming of fibroblasts to hiPSCs produces important differences in cytoplasmic and mitochondrial proteins compared to hESCs, with consequences affecting growth and metabolism. This study improves our understanding of the molecular differences between hiPSCs and hESCs, with implications for potential risks and benefits for their use in future disease modelling and therapeutic applications.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.